Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sten Olsson

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Drug Safety|August 2, 2014
Specific features of medicines safety and pharmacovigilance in AfricaAmbrose O Isah, Shanthi N Pal, Sten Olsson, et al.
International Journal of Health Policy and Management|February 16, 2021
Evaluation of Pharmacovigilance System in IranMalahat Khalili, Hamid Sharifi, Bita Mesgarpour, et al.
Drug Safety|April 9, 2018
The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up StudyHelen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza, et al.
Drug Safety|March 10, 2015
Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in UgandaHelen Ndagije, Victoria Nambasa, Elizabeth Namagala, et al.
Malaria Journal|March 11, 2011
Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug MonitoringAndrea Kuemmerle, Alex N O Dodoo, Sten Olsson, et al.
Plos One|May 10, 2019
The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after studyHelen Byomire Ndagije, Leonard Manirakiza, Dan Kajungu, et al.
Drug Safety|October 5, 2017
Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted CountryKhac-Dung Nguyen, Phuong-Thuy Nguyen, Hoang-Anh Nguyen, et al.
Malaria Journal|November 4, 2020
Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reportingRonald Kiguba, Helen Byomire Ndagije, Victoria Nambasa, et al.
Drug Safety|December 25, 2014
Assessment of a new instrument for detecting preventable adverse drug reactionsRaja Benkirane, Rachida Soulaymani-Bencheikh, Asmae Khattabi, et al.
Malaria Journal|February 12, 2020
Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in UgandaHelen Byomire Ndagije, Ronald Kiguba, Leonard Manirakiza, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Drug Safety|August 2, 2014
Specific features of medicines safety and pharmacovigilance in AfricaAmbrose O Isah, Shanthi N Pal, Sten Olsson, et al.
International Journal of Health Policy and Management|February 16, 2021
Evaluation of Pharmacovigilance System in IranMalahat Khalili, Hamid Sharifi, Bita Mesgarpour, et al.
Drug Safety|April 9, 2018
The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up StudyHelen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza, et al.
Drug Safety|March 10, 2015
Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in UgandaHelen Ndagije, Victoria Nambasa, Elizabeth Namagala, et al.
Malaria Journal|March 11, 2011
Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug MonitoringAndrea Kuemmerle, Alex N O Dodoo, Sten Olsson, et al.
Plos One|May 10, 2019
The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after studyHelen Byomire Ndagije, Leonard Manirakiza, Dan Kajungu, et al.
Drug Safety|October 5, 2017
Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted CountryKhac-Dung Nguyen, Phuong-Thuy Nguyen, Hoang-Anh Nguyen, et al.
Malaria Journal|November 4, 2020
Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reportingRonald Kiguba, Helen Byomire Ndagije, Victoria Nambasa, et al.
Drug Safety|December 25, 2014
Assessment of a new instrument for detecting preventable adverse drug reactionsRaja Benkirane, Rachida Soulaymani-Bencheikh, Asmae Khattabi, et al.
Malaria Journal|February 12, 2020
Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in UgandaHelen Byomire Ndagije, Ronald Kiguba, Leonard Manirakiza, et al.
Pageof 3